Bcl-2 Loss in Breast Cancer Linked to Cell Death and Growth
Author Information
Author(s): H-J van Slooten, MJ van de Vijver, CJH van de Veldel, JH van Dierendonck
Primary Institution: Leiden University Medical Centre
Hypothesis
Does the expression of Bcl-2 in breast cancer correlate with rates of cell death and proliferation?
Conclusion
Loss of Bcl-2 expression in breast cancer is associated with increased cell death and higher proliferation rates.
Supporting Evidence
- High Bcl-2 expression is associated with low rates of apoptotic and necrotic cell death.
- Bcl-2-negative tumors showed a higher apoptotic index compared to Bcl-2-positive tumors.
- High proliferation rates correlate with the absence of Bcl-2 expression.
- Loss of Bcl-2 is linked to increased tumor grade.
Takeaway
In breast cancer, when a protein called Bcl-2 is missing, more cancer cells die, and the remaining cells grow faster.
Methodology
The study analyzed 49 breast cancer tumors for Bcl-2 expression and correlated it with apoptotic and necrotic cell death rates.
Limitations
The study focused only on tumors with extreme Bcl-2 expression levels, which may not represent all cases.
Participant Demographics
Premenopausal, lymph node-negative breast cancer patients.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website